The approval was based on results from the Asian multicenter Phase 3 ENLIGHT UC study (ES101002) and the global ELEVATE UC Phase 3 program (ELEVATE UC 52 and ELEVATE UC 12)...
BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing a Phase 1 clinical study, showing promising early clinical results...
This partnership with Liger Medical reflects our commitment to bringing leading global innovation into China’s healthcare system...
The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE)...
Builds an integrated global commercialisation platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide...
The collaboration is expected to accelerate market access and drive large-scale commercialisation of the new product...
The two agreements are expected to create significant financial and strategic synergies...
The Jianxing centre in East China will be the first CGI centre to install X-ray technology...
Matrix NEO is the world's first automated single-cell analysis platform to achieve medical device clearance, marking a milestone in bringing single-cell sequencing from research laboratories into clinical practice...
The collaboration enables MGI to leverage Swiss Rockets’ strong R&D capabilities and established presence in Europe and the U.S. to commercialise CoolMPS™...
